Compass Therapeutics, Inc. CMPX
1.13
(0.01)
(0.88%)
as of 25 Sep
- Market cap
- $205.3M
- P/E
- 0.0×
Follow CMPX
Insider Buys
alert about insiders buying in the last 12 month
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Mar '19 | Dec '18 | Mar '18 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | 0.00 | — | — | — | — | — | — | — | — |
P/S ratio |
— | 0.00 | — | — | — | — | — | — | — | — |
P/FCF ratio |
— | 0.00 | — | — | — | — | — | — | — | — |
P/Operating CF |
— | (21.74) | — | — | — | — | — | — | — | — |
P/B ratio |
— | 1.59 | — | — | — | — | — | — | — | — |
Price to Tangible BV |
— | 1.59 | — | — | — | — | — | — | — | — |
EV/Sales |
— | 0.00 | — | — | — | — | — | — | — | — |
EV/EBITDA |
— | 0.00 | — | — | — | — | — | — | — | — |
EV/Operating CF |
— | (1.66) | — | — | — | — | — | — | — | — |
EV/FCF |
— | (1.66) | — | — | — | — | — | — | — | — |
Quick Ratio |
14.96 | 14.28 | 19.54 | 11.54 | 13.59 | 4.66 | 2.58 | 0.06 | 0.00 | 0.00 |
Current Ratio |
15.02 | 14.96 | 19.73 | 12.05 | 13.84 | 4.97 | 2.67 | 0.06 | 0.00 | 0.00 |
Net Debt/EBITDA |
2.86 | 2.24 | 2.95 | 4.53 | 1.75 | 1.49 | 0.33 | 0.15 | (4,409.06) | 0.00 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 1.47% | 2.63% | 17.98% | 48.94% | 0.00% | 2,951,469.39% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.02 | 0.03 | 0.23 | (0.13) | 0.00 | (1.71) | 0.00 |
Asset Turnover |
0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.74 | 0.91 | 0.96 | 0.87 | 0.24 | 0.91 | 0.91 | 0.91 | 935.53 | 1.00 |
Capex/Depreciation |
0.12 | (0.43) | 0.02 | (0.03) | (0.89) | 0.02 | (0.22) | — | 0.00 | — |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (41.29%) | (36.07%) | (25.74%) | (24.38%) | (91.30%) | 75.01% | 58.55% | 0.08% | 0.08% | 100.72% | |
| (36.94%) | (33.22%) | (23.84%) | (22.20%) | (79.92%) | (71.70%) | (228.69%) | (734.69%) | (1,469.39%) | 0.00% | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (789.04%) | 0.00% | 0.00% | (0.03%) | 0.00% |
Return on Tangible Assets |
(33.93%) | (39.74%) | (28.91%) | (21.77%) | (59.24%) | (71.55%) | (172.27%) | 50.99% | 1.16% | 101.45% |
Average Days of Receivables |
— | 0.00 | — | — | — | — | — | — | — | 0.00 |
Research and Development Expense of Revenue |
0.00% | 4,981.41% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — | 0.00% | — |
Selling, General and Administrative Expense of Revenue |
0.00% | 1,780.35% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 1,007.06% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — | — | — |
Graham Net Nets |
— | 0.59 | — | — | — | — | — | — | — | — |
Graham Number |
— | 0.00 | — | — | — | — | — | — | — | — |
Earnings Yield |
— | (25.52%) | — | — | — | — | — | — | — | — |
Free Cash Flow Yield |
— | (22.55%) | — | — | — | — | — | — | — | — |
Revenue per Share |
0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(0.31) | (0.33) | (0.32) | (0.32) | (0.31) | (0.87) | (4.74) | (0.01) | (0.65) | (0.01) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | (0.02) | 0.00 | (0.07) | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
(0.31) | (0.33) | (0.32) | (0.32) | (0.34) | (0.87) | (4.81) | (0.01) | (0.65) | (0.01) |
Cash per Share |
1.32 | 0.92 | 1.20 | 1.77 | 2.30 | 1.53 | 3.78 | 0.00 | 0.00 | 0.00 |
Shareholders Equity per Share |
1.25 | 0.91 | 1.17 | 1.73 | 2.23 | 1.30 | (17.73) | (0.01) | (1.63) | (0.01) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
1.25 | 0.91 | 1.17 | 1.73 | 2.23 | 1.30 | (17.73) | (0.01) | (1.63) | (0.01) |
Free Cash Flow |
(49.17) | (44.90) | (40.65) | (34.16) | (21.12) | (26.76) | (32.21) | (0.03) | (33.68) | (0.03) |
Working Capital |
195.85 | 123.88 | 146.08 | 178.62 | 136.47 | 40.10 | 16.42 | (0.07) | (8.46) | (0.03) |
Capital Expenditures |
(0.02) | (0.04) | (0.03) | (0.04) | (1.45) | 0.04 | (0.47) | — | (2.02) | — |
Net Current Asset Value |
187.02 | 117.58 | 145.54 | 176.78 | 133.43 | 38.24 | (122.75) | (0.07) | (149.39) | (0.03) |
EV/EBIT |
— | 0.00 | — | — | — | — | — | — | — | — |
Capex to Sales |
0.00 | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Net Profit Margin |
0.00% | (5,808.82%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Price to Operating Income |
— | 0.00 | — | — | — | — | — | — | — | — |
| Other line items | ||||||||||
Depreciation/Fixed assets |
(1.97) | 0.29 | (1.49) | 0.70 | 0.72 | 2.14 | 0.57 | — | 0.36 | — |
Cash ROIC |
(12.14%) | (17.94%) | (13.79%) | (9.62%) | (7.59%) | (28.99%) | 45.25% | 49.92% | (65.24%) | 101.16% |
Accounts Receivable Turnover |
— | 0.00 | — | — | — | — | — | — | — | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | — |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | — |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | — |
Average Payables |
1.92 | 3.17 | 3.74 | 2.12 | 0.96 | 0.85 | 1.18 | — | 1.18 | — |
Average Assets |
180.00 | 148.64 | 178.26 | 176.70 | 102.83 | 41.15 | 15.19 | 0.00 | 0.00 | 0.00 |
Average Common Equity |
161.01 | 136.89 | 165.09 | 160.86 | 90.01 | (39.33) | (59.34) | (42.42) | (42.40) | (0.03) |
Columns are period end dates